Global Cardiac Marker Analyzer 麻豆原创 and Forecast, Impact of COVID-19, Product Analysis, Companies Business & 麻豆原创ing Strategy, Major Deals

You are here: 麻豆原创 Catalog Pharma & Healthcare Diagnostics IT & eHealth Medical Devices Research & Development (Pharma & Healthcare)

Global Cardiac Marker Analyzer 麻豆原创 and Forecast, Impact of COVID-19, Product Analysis, Companies Business & 麻豆原创ing Strategy, Major Deals

麻豆原创 Research Report Summary

Global Cardiac Marker Analyzer 麻豆原创 and Forecast, Impact of COVID-19, Product Analysis, Companies Business & 麻豆原创ing Strategy, Major Deals report is published on February 9, 2022 and has 118 pages in it. This market research report provides information about Pharma & Healthcare, Diagnostics, IT & eHealth, Medical Devices, Research & Development (Pharma & Healthcare) industry. It covers Global market data and forecasts. It is priced starting at USD 1,790.00 for Single User License (PDF) which allows one person to use this report.

Please read the description and table of contents of this research report given below to check whether it meets your research requirements. If not, then please do not hesitate to contact us using "Report Enquiry" form given below. We can customize this research report or suggest a new fully customized market research report to meet your research goals and data requirements.

Global Cardiac Marker Analyzer 麻豆原创 and Forecast, Impact of COVID-19, Product Analysis, Companies Business & 麻豆原创ing Strategy, Major Deals

Printer version

Send by email

Publication ID:听

IGT0720002

Publication Date:听

February 9, 2022

笔补驳别蝉:听

118

笔耻产濒颈蝉丑别谤:听

iGATE

颁辞耻苍迟谤颈别蝉:听

Global

USD 1,790.00

Pay By Invoice

If you wish to purchase this report using bank/wire transfer against an invoice, please fill your details using request invoice form given below.

Globally Trusted Brand

We help executives from firms听to Start-ups听with their market research needs thus听we can help you too.听

Secure Checkout

You can shop confidently as your online payments are processed using PCI DSS compliant secure payment gateways on our website.

Frequently Asked Questions

If you have any pre-sales听questions related to this report please let us know using the "Report Enquiry" form below. This will help us provide you听with answers听so that you can purchase with confidence. If you wish to read about frequently asked questions by our customers please visit our .

Tabs

Description

The global Cardiac Marker Analyzer market is predicted to reach US$ 4.75 Billion by 2027. Cardiac Marker analyzer represents a paradigm in diagnostics that provides high sensitivity and reliable information in minutes. The cardiac biomarkers that are widely used as an integrated diagnostic approach for CVDs include CK-MB, troponin I and T, myoglobin, BNPs, IMA and few others. The prevention of cardiac diseases by monitoring the heart conditions via cardiac biomarker testing is the profound approach for obtaining rapid results for immediate diagnosing and treatment.

Cardiac biomarkers are used as risk stratification for various cardiovascular diseases (CVDs), which include myocardial infraction, congestive heart failure, acute coronary syndrome (ACS) among others. It is ideally suited to both point of care testing and laboratory use. The factors such as increasing incidences of cardiovascular diseases, rapidly increasing geriatric population, growing funding from public-private organizations for research on cardiac biomarkers, and ongoing clinical trials for the identification of novel cardiac biomarkers are driving the growth of the market. However, factors such as technical problems related to sample collection and storage and issues related to regulatory and reimbursement systems are some of the key factors hampering the growth of this market.

Impact of COVID-19 on Global Cardiac Marker Analyzer 麻豆原创

The COVID-19 outbreak has become a global stress test. As the number of people infected with the virus continues to rise around the world, uncertainties about global economic growth increases. The COVID-19 disease has infected around 392 Million people worldwide. Globally the death toll has reached 5,745,435 according to the latest statistics from the Worldometers (as of February 5, 2022). The number is still growing, and the duration of the pandemic is still difficult to predict. The COVID-19 pandemic has restricted the growth of the Cardiac Marker Analyzer market, by social restrictions and other precautionary measures taken in response to the COVID-19 pandemic. However, as governments began lifting social restrictions, the negative trend in the revenues of these businesses began to level off and stabilize prior to the third quarter of 2020. In the years to come, physicians are likely to witness an increase in influx of patients, hence driving the cardiac marker analyzer market.

Key Highlights of the Report

In October 2017, Abbott completed its acquisition of Alere, concluding a deal first announced in February 2016.
Abbott Point of Care Diagnostics sales is driven by continued adoption of Abbott's i-STAT handheld system.
In 2020, Quidel's cardiac immunoassay and specialized diagnostic solutions revenue declined, mainly due to lower demand during the COVID-19 pandemic.
Cobas H232 POC system permits rapid and easy determination of cardiac blood markers such as Troponin T, NT-proBNP, D-dimer, CK-MB and myoglobin.
A major focus of Response Biomedical development programs in cardiovascular testing has been clinical tests for the quantification of cardiovascular markers.
In 2020, Abbott Point of Care Diagnostics sales declined, driven by lower demand during the COVID-19 pandemic. However, in 2021, Abbott Point of Care Diagnostics sales returned to pre-pandemic level.
In March 2020, Siemens Healthineers announced market introduction of the teamplay digital health platform.
CardioGenics is the only company to successfully deploy CL in a compact, fully automated POC platform.
Siemens Healthineers launched the third phase of its Strategy 2025 with the beginning of fiscal year 2022.
Trinity Biotech Point-of-Care revenues declined in 2020 by around 19.1% from the previous year figure.

iGATE RESEARCH report titled "Global Cardiac Marker Analyzer 麻豆原创 and Forecast, Impact of COVID-19, Product Analysis, Companies Business & 麻豆原创ing Strategy, Major Deals" provides a comprehensive assessment of the cardiac marker analyzer segments, comparative tests analysis, competitive product analysis, product features & benefits, merger & acquisitions, strategic alliances and Companies Business and 麻豆原创 Strategies.

This 118 Page report with 11 Figures and 19 Tables has been studied from 8 View Points:

1. Cardiac Marker Analyzer 麻豆原创 & Forecast (2011 - 2027)

2. Impact of COVID-19 on Global Cardiac Marker Analyzer 麻豆原创

3. Cardiac Marker Companies - Comparative Tests Analysis

4. Cardiac Marker Analyzer - Competitive Product Analysis

5. Cardiac Marker Analyzer - Specifications, Product Features & Benefits Analysis

6. Cardiac Marker Analyzer - Mergers, Acquisitions, Distribution, Partnership and Licensing Agreements

7. Emerging Markers Analysis

8. Companies Business & 麻豆原创ing Strategy

The Cardiac Marker Analyzer Covered in the report are as follows:

1. Triage MeterPro Analyzer

2. The i-STAT System

3. Cobas h 232 POC System

4. Access 2 Immunoassay System

5. Stratus CS Analyzer

6. RAMP 200

7. RAMP Reader

8. i-chroma DUO Analyzer

9. DXpress Reader Analyzer

10. PATHFAST Analyzer

11. QL Care Analyzer

12. Meritas POC Analyzer

Cardiac Marker Analyzer - Key Company Analysis

1. Alere (Now Abbott)

2. Abbott Point of Care

3. Quidel Corporation

4. Roche

5. Beckman Coulter

6. Siemens Healthineers

7. Response Biomedical

8. Boditech

9. Lifesign

10. LSI Medience Corporation

11. CardioGenics Holdings Inc.

12. Trinity Biotech

Table of Contents

1. Executive Summary

2. Impact of COVID-19 on Global Cardiac Marker Analyzer 麻豆原创

3. Global Cardiac Marker Analyzer 麻豆原创 & Forecast (2011 - 2027)

4. Cardiac Marker Companies - Comparative Tests Analysis

5. Cardiac Marker Analyzer - Competitive Product Analysis

6. Alere (Now Abbott)

6.1 Alere Triage
- 6.1.1 Alere Cardiology Net Sales (2010 - 2016)

7. Quidel Corporation

7.1 Quidel Triage system
- 7.1.1 Quidel Cardiac Immunoassay Net Sales (2017 - 2027)

8. Abbott Point of Care

8.1 The i-STAT System
8.2 Abbott Laboratories Point of Care Diagnostics Sales (2011 - 2027)

9. Roche

9.1 Cobas h 232 POC System

10. Beckman Coulter

10.1 Access 2 Immunoassay System

11. Siemens Healthineers

11.1 Stratus CS Analyzer
11.2 Siemens Healthineers establishes global Digital Ecosystem to drive Digitalization of Healthcare

12. Response Biomedical

12.1 Cardiovascular Testing
- 12.1.1 Acute Myocardial Infarction (Heart Attack) Testing
- 12.1.2 Congestive Heart Failure ("CHF") Testing
- 12.1.3 Thrombotic Disease Testing
12.2 RAMP Platform
- 12.2.1 RAMP 200
- 12.2.2 RAMP Reader
12.3 Response Cardiovascular Testing
- 12.3.1 RAMP TROPONIN I
- 12.3.2 RAMP NT-proBNP
- 12.3.3 RAMP MYOGLOBIN
- 12.3.4 RAMP CK-MB
- 12.3.5 RAMP D-DIMER
12.4 Response Biomedical Cardiovascular Net Sales (2010 - 2026)

13. Boditech

13.1 i-chroma II Analyzer

14. Lifesign

14.1 DXpress Reader Analyzer

15. LSI Medience Corporation

15.1 PATHFAST Analyzer

16. CardioGenics Holdings Inc.

16.1 QL Care Analyzer

17. Trinity Biotech

17.1 Meritas POC Analyzer
17.2 Trinity Biotech Point of Care Diagnostics Sales (2010 - 2027)

18. Mergers, Acquisitions and Licensing Agreements

18.1 Alere Inc
18.2 CardioGenics
18.3 Response Biomedical
18.4 Abbott Laboratories
18.5 Siemens Healthineers
18.6 LSI Medience Corporation
18.7 Trinity Biotech
18.8 Quidel

19. Emerging Markers

20. Response Biomedical - Business & 麻豆原创ing Strategy

20.1 Point 1
20.2 Point 2
20.3 Point 3
20.4 Point 4

21. Roche - Business & 麻豆原创ing Strategy

21.1 Point 1
21.2 Point 2
21.3 Point 3

22. Boditech Med Inc - Business and 麻豆原创ing Strategy

22.1 Point 1
22.2 Point 2

23. Siemens Healthineers - Business and 麻豆原创ing Strategy

23.1 Point 1
23.2 Point 2
23.3 Point 3
23.4 Point 4
23.5 Point 5
23.6 Point 6
23.7 Point 7
23.8 Point 8

Tables and Figures

List of Figures:

Figure 3-1: Global - Cardiac Marker Analyzer 麻豆原创 (Million US$), 2011 - 2021
Figure 3-2: Global - Forecast for Cardiac Marker Analyzer 麻豆原创 (Million US$), 2022 - 2027
Figure 6-1: Global - Alere Cardiology Net Sales (Million US$), 2010 - 2016
Figure 7-1: Quidel - Cardiac Immunoassay Revenue (Million US$), 2017 - 2021
Figure 7-2: Quidel - Forecast for Cardiac Immunoassay Revenue (Million US$), 2022 - 2027
Figure 8-1: Global - Abbott Laboratories Point of Care Diagnostics Sales (Million US$), 2011 - 2021
Figure 8-2: Global - Forecast for Abbott Laboratories Point of Care Diagnostics Sales (Million US$), 2022 - 2027
Figure 12-1: Global - Response Biomedical Cardiovascular Product Sales (Million US$), 2010 - 2021
Figure 12-2: Global - Forecast for Response Biomedical Cardiovascular Product Sales (Million US$), 2022 - 2027
Figure 17-1: Global - Trinity Biotech Point of Care Diagnostics Sales (Million US$), 2010 - 2019
Figure 17-2: Global - Forecast for Trinity Biotech Point of Care Diagnostics Sales (Million US$), 2022 - 2027

List of Tables:

Table 4-1: Cardiac Marker Companies - Comparative Tests Analysis
Table 4-2: Cardiac Marker Companies - Comparative Tests Analysis
Table 4-3: Cardiac Marker Companies - Comparative Tests Analysis
Table 5-1: Cardiac Marker Analyzer - Competitive Product Analysis
Table 5-2: Cardiac Marker Analyzer - Competitive Product Analysis
Table 6-1: Alere - Triage Product Analytes
Table 15-1: PATHFAST - Technical Specifications
Table 18-1: Alere - Merger & Acquisition, 2007 - 2017
Table 18-2: Alere - Distribution/Partnership Agreement, 2008, 2016
Table 18-3: CardioGenics - Mergers & Acquisition, 2015
Table 18-4: CardioGenics - Licensing Agreement, 2012
Table 18-5: Response Biomedical - Distribution Agreement, 2011 - 2015
Table 18-6: Response Biomedical - Collaboration Deal, 2004 - 2015
Table 18-7: Abbott Laboratories - Merger & Acquisition, 2003, 2017, 2019
Table 18-8: Siemens Healthineers - Merger & Acquisition, 2017
Table 18-9: Siemens Healthineers - Strategic Partnership, 2017
Table 18-10: LSI Medience Corporation - Strategic Alliance, 2014
Table 18-11: Trinity Biotech - Merger & Acquisition, 2012
Table 18-12: Quidel Corporation - Merger & Acquisition, 2017

Report License Types

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

Enquiry / Request Invoice

Report Inquiry

Do you have more questions related to this market research report after going through the description and table of contents?

We are here to help. Please use the form given below to let us know your questions related to this report.

Kindly use your official email address and contact number to ensure speedy response.

First Name *

Last Name *

Company *

Email Address *

Phone (Including International Code) *

Report Title *

Do you need invoice for purchasing this report? *

Address 1

Address 2

City/Town

Postal/Zip Code

Country

License Type

Your Inquiry *

CAPTCHA

This question is for testing whether you are a human visitor and to prevent automated spam submissions.

Research & Development (Pharma & Healthcare)

*Please note that the report cover image shown above is for representation purpose only. Actual report cover may vary.

听

Related 麻豆原创 Research Reports

Publication	Price
Global Drug and Medical Device Development Testing 麻豆原创 Growth (Status and Outlook) 2025-2031 The global Drug and Medical Device Development Testing market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis...Read more	USD 3,660.00
Global Molecular Biology Automatic Analyzer 麻豆原创 Growth 2025-2031 The global Molecular Biology Automatic Analyzer market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. The automatic biochemical analyzer combines biochip platform technology with biochemical detection technology, and encapsulates a small amount of detection reagents in a one-time-use small microfluidic chip through a special freeze-drying process. It can detect and record various biochemical indicators, and can carry out statistical analysis and long-term tracking of the detection data. United States market for Molecular Biology Automatic Analyzer is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. China market for Molecular Biology Automatic Analyzer is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. Europe market for Molecular Biology Automatic Analyzer...Read more	USD 3,660.00
Global Disposable Blood Filters 麻豆原创 Growth 2025-2031 The global Disposable Blood Filters market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment....Read more	USD 3,660.00
Global Biological Safety and Biocompatibility Testing 麻豆原创 Growth 2025-2031 The global Biological Safety and Biocompatibility Testing market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. Safety testing听includes a set of assays used to test preclinical and clinical vector product lots prior to use in animals or humans. United States market for Biological Safety and Biocompatibility Testing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. China market for Biological Safety and Biocompatibility Testing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. Europe market for Biological Safety and Biocompatibility Testing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. Global key Biological Safety and Biocompatibility Testing players cover Charles River...Read more	USD 3,660.00
Global Plasma Separation Equipment 麻豆原创 Growth 2025-2031 The global Plasma Separation Equipment market size is predicted to grow from US$ 1148 million in 2025 to US$ 1660 million in 2031; it is expected to grow at a CAGR of 6.3% from 2025 to 2031. According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis...Read more	USD 3,660.00

Clients Who Trust Us

Need tailor made market research solution? We can help you with that too.

Contact Us

About Us

At 麻豆原创 we aim to make it easier for decision makers to find relevant information and locate right market research reports which can save their time and assist in what they do best, i.e. take time-critical decisions.

We work with our associate Global market research firms who are known leaders in their respective domains to obtain right market research solution for our customer鈥檚 needs, be it custom research or syndicated research reports.

Contact Us

麻豆原创 Research Reports, Inc
16192 Coastal Hwy
Lewes, DE 19958, USA

USA: +1-302-703-9904

India: +91-8762746600

marketresearchreports

info@marketresearchreports.com

Latest Blog Posts

Stay Connected

Disclaimer: 麻豆原创 has no affiliation to, and is not associated with any other website(s) or organization(s). We offer syndicated research reports (like country analysis, SWOT analysis, competitive intelligence, industry reports, company reports and market analysis & trends reports) and custom market research from our website 麻豆原创ResearchReports.com only.

If you are looking for a market research solution for your research requirements, please begin your search using the search box on top of this page or use our chat system to speak to our market research consultants or directly write to us.

麻豆原创

Search form